(S (PP (IN With) (NP (NP (NP (DT the) (NN shortage)) (PP (IN of) (NP (NNS physicians) (CC and) (NNS surgeons)))) (CC and) (NP (NP (VB increase)) (PP (IN in) (NP (NN demand))) (ADVP (NN worldwide)) (PP (JJ due) (TO to) (NP (NP (NNS situations)) (PP (JJ such) (IN as) (NP (DT the) (NNP COVID-19) (NN pandemic)))))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (VBG growing) (NN interest)) (PP (IN in) (S (VP (VBG finding) (NP (NP (NNS solutions)) (SBAR (S (VP (TO to) (VP (VB help) (S (VP (VB address) (NP (DT the) (NN problem)))))))))))))) (. .))
(S (NP (NP (DT A) (NN solution)) (PP (TO to) (NP (DT this) (NN problem)))) (VP (MD would) (VP (VB be) (S (VP (TO to) (VP (VB use) (NP (NN neurotechnology)) (S (VP (TO to) (VP (VB provide) (NP (PRP them)) (NP (VBN augmented) (NN cognition) (, ,) (NNS senses) (CC and) (NN action)) (PP (IN for) (NP (JJ optimal) (NN diagnosis) (CC and) (NN treatment))))))))))) (. .))
(S (ADVP (RB Consequently)) (, ,) (S (VP (VBG doing) (ADVP (RB so)))) (VP (MD can) (VP (ADVP (RB negatively)) (VB impact) (NP (PRP them) (CC and) (NNS others)))) (. .))
(S (NP (PRP We)) (VP (VBP argue) (SBAR (IN that) (S (S (VP (VBG applying) (NP (NN neurotechnology)) (PP (IN for) (NP (JJ human) (NN enhancement))) (PP (IN in) (NP (NNS physicians) (CC and) (NNS surgeons))))) (VP (MD can) (VP (VB cause) (NP (NP (NNS injustices)) (, ,) (CC and) (NP (NN harm))) (PP (TO to) (NP (PRP them) (CC and) (NNS patients)))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (MD will) (ADVP (RB first)) (VP (VB describe) (NP (NP (DT the) (NNS augmentations) (CC and) (NNS neurotechnologies)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB achieve) (NP (DT the) (JJ relevant) (NNS augmentations)) (PP (IN for) (NP (NNS physicians) (CC and) (NNS surgeons)))))))))))))) (. .))
(S (NP (PRP We)) (VP (MD will) (ADVP (RB then)) (VP (VP (VB review) (NP (NP (VBD selected) (JJ ethical) (NNS concerns)) (VP (VBN discussed) (PP (IN within) (NP (NN literature)))))) (, ,) (VP (VB discuss) (NP (NP (DT the) (NN neuroengineering)) (PP (IN behind) (S (VP (VBG using) (NP (NN neurotechnology)) (PP (IN for) (NP (NN augmentation) (NNS purposes)))))))) (, ,) (ADVP (RB then)) (VP (NN conclude) (PP (IN with) (NP (NP (DT an) (NN analysis)) (PP (IN on) (NP (NP (NP (NNS outcomes)) (CC and) (NP (JJ ethical) (NNS issues))) (PP (IN of) (S (VP (VBG implementing) (NP (JJ human) (NN augmentation)) (PP (IN via) (NP (NN neurotechnology))) (PP (IN in) (NP (ADJP (JJ medical) (CC and) (JJ surgical)) (NN practice))))))))))))) (. .))
